Cytoskeletal Tropomyosin as a Biomarker in Clostridium difficile Infection.

Elena A Usacheva, Lance R Peterson,Katherine Mendoza,Donna M Schora,M Moazzem Hossain,Jian-Ping Jin

Journal of clinical medicine research（2019）

引用 1|浏览24

暂无评分

摘要

Tpm has a potential role as a CDI biomarker in combination with PCR and an appropriate clinical evaluation. However, non-muscle Tpm, as a biomarker for CDI, suffers from a low sensitivity in our study. Therefore further investigation using larger cohorts is needed.

查看译文

关键词

Biomarker,Clostridium difficile infection,Diagnostics,Tropomyosin

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要